Policy Statement Archives - Heart Valve Voice US https://www.heartvalvevoice-us.org/category/policy-center/policy-statement/ Giving a voice to people with heart valve disease Thu, 09 Sep 2021 13:21:25 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.1 https://www.heartvalvevoice-us.org/wp-content/uploads/2019/02/cropped-Favicon-32x32.png Policy Statement Archives - Heart Valve Voice US https://www.heartvalvevoice-us.org/category/policy-center/policy-statement/ 32 32 Comments on Cures 2.0 Discussion Draft https://www.heartvalvevoice-us.org/comments-on-cures-2-0-discussion-draft/ Mon, 26 Jul 2021 18:54:06 +0000 https://www.heartvalvevoice-us.org/?p=10971 Honorable Diana DeGetteHonorable Fred Upton Comments on Cures 2.0 Discussion Draft Dear Representatives DeGette and Upton: Thank you for your continued bi-partisan efforts to advance medical innovation benefittingpatients. Heart Valve Voice US is a nonprofit patient advocacy organization providing a unitedvoice for people living with heart valve disease. We advocate for early detection, meaningfulsupport, and […]

The post Comments on Cures 2.0 Discussion Draft appeared first on Heart Valve Voice US.

]]> Medicare Program; Medicare Coverage of Innovative Technology (MCIT) and Definition of “Reasonable and Necessary”; Delay of Effective Date (Docket No. CMS-2021-05490) https://www.heartvalvevoice-us.org/medicare-program-medicare-coverage-of-innovative-technology-mcit-and-definition-of-reasonable-and-necessary-delay-of-effective-date-docket-no-cms-2021-05490/ Tue, 20 Apr 2021 21:12:00 +0000 https://www.heartvalvevoice-us.org/?p=10886 The Heart Valve Disease Policy Task Force represents a diverse group of patient,disease, and research advocacy groups with a shared interest of ensuring that patientshave access to safe, innovative new technologies – “Breakthrough Devices” – as soonas possible after receiving market authorization from the Food and Drug Administration. While we understand the rationale behind delaying […]

The post Medicare Program; Medicare Coverage of Innovative Technology (MCIT) and Definition of “Reasonable and Necessary”; Delay of Effective Date (Docket No. CMS-2021-05490) appeared first on Heart Valve Voice US.

]]> HVVUS Expresses Thoughts On Medicare Coverage for Innovative Technologies https://www.heartvalvevoice-us.org/hvvus-expresses-thoughts-on-medicare-coverage-for-innovative-technologies/ Tue, 10 Nov 2020 15:56:52 +0000 https://hvvprod.wpengine.com/?p=10718 Heart Valve Voice US is a nonprofit patient advocacy organization that provides a united voicefor people living with heart valve disease. We advocate for early detection, meaningful support,and timely access to appropriate treatment for all people affected by heart valve disease. Theprimary goal of this proposed rule aligns with our mission and we look forward […]

The post HVVUS Expresses Thoughts On Medicare Coverage for Innovative Technologies appeared first on Heart Valve Voice US.

]]> HVV US is advocating for patients with mitral valve disease. See our comments to CMS https://www.heartvalvevoice-us.org/hvv-us-is-advocating-for-patients-with-mitral-valve-disease-see-our-comments-to-cms/ Fri, 07 Aug 2020 15:50:20 +0000 https://hvvprod.wpengine.com/?p=10681 Telehealth offers significant advantages to patients of all types, including and especially older Americans with mobility and other age-associated health conditions. We believe telehealth is not a trend but an important tool to facilitate safe, convenient, efficient access for patients. The new minimum surgical procedure thresholds for both new and established TEER programs have no scientific basis, […]

The post HVV US is advocating for patients with mitral valve disease. See our comments to CMS appeared first on Heart Valve Voice US.

]]> Need for Patient Input Regarding Resumption of Cardiovascular Procedures https://www.heartvalvevoice-us.org/need-for-patient-input-regarding-resumption-of-cardiovascular-procedures/ Wed, 06 May 2020 20:21:54 +0000 https://hvvprod.wpengine.com/?p=10582 To download this page as a PDF, click here. Heart Valve Voice US is deeply concerned that the patient perspective was omitted from the recent guidance on resuming cardiovascular procedures released in the Journal of American College of Cardiology and endorsed by more than one dozen medical societies. On April 20, 2020, Heart Valve Voice […]

The post Need for Patient Input Regarding Resumption of Cardiovascular Procedures appeared first on Heart Valve Voice US.

]]> CMS Makes Progress but Continues to Limit Life-Saving Access for Heart Valve Disease Patients https://www.heartvalvevoice-us.org/cms-makes-progress-but-continues-to-limit-life-saving-access-for-heart-valve-disease-patients/ Thu, 28 Mar 2019 14:48:36 +0000 https://hvvprod.wpengine.com/?p=7352 Washington, D.C., March 27, 2019 – Below is a statement issued on behalf of the Alliance for Aging Research, Association of Black Cardiologists, Heart Valve Voice US, and Mended Hearts in response to the Centers for Medicare and Medicaid Services’ proposed decision to cover Transcatheter Aortic Valve Replacement (TAVR) for the treatment of symptomatic aortic valve stenosis […]

The post CMS Makes Progress but Continues to Limit Life-Saving Access for Heart Valve Disease Patients appeared first on Heart Valve Voice US.

]]>